{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:03:03Z","timestamp":1780394583450,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neurol.2025.09.005","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:46:53Z","timestamp":1760532413000},"page":"955-969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Disease modifying treatment of radiologically isolated syndrome: A systematic review of the use, efficacy, effectiveness, and safety"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2839-2240","authenticated-orcid":false,"given":"D.","family":"Ripsman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tremlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Makhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neurol.2025.09.005_bib0230","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","article-title":"Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome","volume":"72","author":"Okuda","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2025.09.005_bib0235","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3174\/ajnr.A4660","article-title":"Incidence of radiologically isolated syndrome: a population-based study","volume":"37","author":"Forslin","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.neurol.2025.09.005_bib0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jnnp.2009.180000","article-title":"Incidental MRI lesions suggestive of multiple sclerosis in asymptomatic patients in Karachi, Pakistan","volume":"82","author":"Wasay","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.neurol.2025.09.005_bib0245","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.25799","article-title":"radiologically isolated syndrome: 10-year risk estimate of a clinical event","volume":"88","author":"Lebrun-Frenay","year":"2020","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2025.09.005_bib0250","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/1352458509106214","article-title":"Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease","volume":"15","author":"Siva","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2025.09.005_bib0255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.msard.2019.04.030","article-title":"Assessing cognitive performance in radiologically isolated syndrome","volume":"32","author":"Menascu","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"10.1016\/j.neurol.2025.09.005_bib0260","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1093\/brain\/awad073","article-title":"The radiologically isolated syndrome: revised diagnostic criteria","volume":"146","author":"Lebrun-Fr\u00e9nay","year":"2023","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neurol.2025.09.005_bib0265","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/WCO.0000000000000700","article-title":"Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm","volume":"32","author":"Cree","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2025.09.005_bib0270","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/13524585231172945","article-title":"or radiologically isolated syndrome (RIS) should be actively monitored and treated\u00a0\u2013\u00a0NO","volume":"29","author":"Smets","year":"2023","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.neurol.2025.09.005_bib0275","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/13524585231172943","article-title":"Presymptomatic MS or radiologically isolated syndrome should be actively monitored and treated: yes","volume":"29","author":"Lebrun-Frenay","year":"2023","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2025.09.005_bib0280","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.neurol.2025.09.005_bib0285","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023)","article-title":"Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence","author":"Ch\u00fcnemann","year":"2023"},{"issue":"15","key":"10.1016\/j.neurol.2025.09.005_bib0290","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of Observational Studies in Epidemiology. A proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2025.09.005_bib0295","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.neurol.2025.09.005_bib0300","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2013"},{"key":"10.1016\/j.neurol.2025.09.005_bib0305","first-page":"e232815","article-title":"Teriflunomide and time to clinical multiple sclerosis in patients with radiologically isolated syndrome: the TERIS Randomized Clinical Trial","volume":"21","author":"Lebrun-Fr\u00e9nay","year":"2023","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.09.005_bib0310","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ana.26555","article-title":"Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome","volume":"93","author":"Okuda","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2025.09.005_bib0315","doi-asserted-by":"crossref","first-page":"103600","DOI":"10.1016\/j.msard.2022.103600","article-title":"Radiologically isolated syndrome conversion to multiple sclerosis","volume":"59","author":"Sabeti","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2025.09.005_bib0320","doi-asserted-by":"crossref","first-page":"103183","DOI":"10.1016\/j.msard.2021.103183","article-title":"Radiologically isolated syndrome: a single-center, retrospective cohort study","volume":"55","author":"George","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2025.09.005_bib0325","doi-asserted-by":"crossref","first-page":"103049","DOI":"10.1016\/j.msard.2021.103049","article-title":"COVID-19 in Argentine teriflunomide-treated multiple sclerosis patients: first national case series","volume":"53","author":"Luetic","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"10","key":"10.1016\/j.neurol.2025.09.005_bib0330","doi-asserted-by":"crossref","first-page":"e2128271","DOI":"10.1001\/jamanetworkopen.2021.28271","article-title":"Risk factors and time to clinical symptoms of multiple sclerosis among patients with radiologically isolated syndrome","volume":"4","author":"Lebrun-Fr\u00e9nay","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.neurol.2025.09.005_bib0335","article-title":"Intrathecally produced CXCL13: a predictive biomarker in multiple sclerosis","volume":"6","author":"DiSano","year":"2020","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"4","key":"10.1016\/j.neurol.2025.09.005_bib0340","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/brain\/awy021","article-title":"Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome","volume":"141","author":"Matute-Blanch","year":"2018","journal-title":"Brain"},{"issue":"3 Supplement 1","key":"10.1016\/j.neurol.2025.09.005_bib0345","first-page":"764","article-title":"Risk of developing cancer and its impact on patients with multiple sclerosis under treatment with immunomodulators","volume":"23","author":"Curbelo","year":"2017","journal-title":"Mult Scler J"},{"issue":"6","key":"10.1016\/j.neurol.2025.09.005_bib0350","doi-asserted-by":"crossref","first-page":"e395","DOI":"10.1212\/NXI.0000000000000395","article-title":"Radiologically isolated syndrome in children: clinical and radiologic outcomes","volume":"4","author":"Makhani","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"10.1016\/j.neurol.2025.09.005_bib0355","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1212\/WNL.0b013e31820d8b1d","article-title":"Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome","volume":"76","author":"Okuda","year":"2011","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurol.2025.09.005_bib0360","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","article-title":"Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome","volume":"72","author":"Okuda","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2025.09.005_bib0365","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jnnp.2006.108274","article-title":"Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile","volume":"79","author":"Lebrun","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.09.005_bib0370","doi-asserted-by":"crossref","first-page":"1145260","DOI":"10.3389\/fneur.2023.1145260","article-title":"Should we treat pediatric radiologically isolated syndrome? An 18-year follow-up case report","volume":"14","author":"Barbuti","year":"2023","journal-title":"Front Neurol"},{"issue":"5 Supplement","key":"10.1016\/j.neurol.2025.09.005_bib0375","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.eprac.2023.03.164","article-title":"Rare case of asymptomatic multiple sclerosis lesions in hyperprolactinemia","volume":"29","author":"Upadhyay","year":"2023","journal-title":"Endocr Pract"},{"issue":"9","key":"10.1016\/j.neurol.2025.09.005_bib0380","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.3390\/jcm12093284","article-title":"A case report of pediatric patient with tuberous sclerosis and radiologically isolated syndrome","volume":"12","author":"Sforza","year":"2023","journal-title":"J Clin Med"},{"issue":"16 Supplement","key":"10.1016\/j.neurol.2025.09.005_bib0385","article-title":"Radiologically isolated syndrome: pathologically defined as demyelinating disease (P1.391) discussion","volume":"86","author":"Keegan","year":"2016","journal-title":"Neurol"},{"issue":"14","key":"10.1016\/j.neurol.2025.09.005_bib0390","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1177\/1352458514523693","article-title":"The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): a single case report follow-up study","volume":"20","author":"D\u2019Anna","year":"2014","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.neurol.2025.09.005_bib0395","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00415-013-7015-y","article-title":"New daily persistent headache and radiologically isolated syndrome","volume":"260","author":"Aguiar de Sousa","year":"2013","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2025.09.005_bib0400","doi-asserted-by":"crossref","first-page":"e030266","DOI":"10.1136\/bmjopen-2019-030266","article-title":"Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis","volume":"10","author":"Shamsrizi","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.neurol.2025.09.005_bib0405","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jclinepi.2019.10.011","article-title":"Excluding non-English publications from evidence-syntheses did not change conclusions: a meta-epidemiological study","volume":"118","author":"Nussbaumer-Streit","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.neurol.2025.09.005_bib0410","doi-asserted-by":"crossref","first-page":"e208099","DOI":"10.1212\/WNL.0000000000208099","article-title":"Off-road testing: outcome reporting bias in multiple sclerosis trials","volume":"102","author":"Marrie","year":"2024","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.neurol.2025.09.005_bib0415","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1517\/14656566.2013.826190","volume":"14","author":"Havrdova","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"10.1016\/j.neurol.2025.09.005_bib0420","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S1474-4422(14)70191-7","article-title":"Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"13","author":"Miller","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.09.005_bib0425","doi-asserted-by":"crossref","first-page":"e208032","DOI":"10.1212\/WNL.0000000000208032","article-title":"Outcome reporting bias in clinical trials researching disease-modifying therapy in patients with multiple sclerosis","volume":"102","author":"Lemmens","year":"2024","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurol.2025.09.005_bib0430","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/14740338.2020.1805430","article-title":"Long-term drug treatment in multiple sclerosis: safety success and concerns","volume":"19","author":"Jakimovski","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"10.1016\/j.neurol.2025.09.005_bib0435","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s13311-021-01073-y","article-title":"Association between disease-modifying therapies prescribed to persons with multiple sclerosis and cancer: a WHO Pharmacovigilance Database Analysis","volume":"18","author":"Dolladille","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.neurol.2025.09.005_bib0440","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3988\/jcn.2022.0348","article-title":"Outcome of COVID-19 infection in patients with multiple sclerosis who received disease-modifying therapies: a systematic review and meta-analysis","volume":"19","author":"Liu","year":"2023","journal-title":"J Clin Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2025.09.005_bib0445","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12883-022-02738-7","article-title":"Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis","volume":"22","author":"Fox","year":"2022","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurol.2025.09.005_bib0450","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jpsychires.2015.05.008","article-title":"Psychiatric disturbances in radiologically isolated syndrome","volume":"68","author":"Labiano-Fontcuberta","year":"2015","journal-title":"J Psychiatr Res"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725006125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725006125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:33:37Z","timestamp":1765413217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725006125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0035378725006125"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.09.005","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease modifying treatment of radiologically isolated syndrome: A systematic review of the use, efficacy, effectiveness, and safety","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}